MDE Group’s AstraZeneca AZN Stock Holding History

MDE Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$237K	Hold	3,463	–	–	0.06%	52
2014 Q4	$244K	Hold	3,463	–	–	0.06%	52
2014 Q3	$247K	Sell	3,463 -505	-13%	-$37K	0.06%	53
2014 Q2	$295K	Sell	3,968 -3,380	-46%	-$244K	0.07%	54
2014 Q1	$477K	Buy	7,348 +23	+0.3%	+$1.49K	0.1%	31
2013 Q4	$435K	Sell	7,325 -60	-0.8%	-$3.26K	0.07%	32
2013 Q3	$384K	Sell	7,385 -400	-5%	-$20.1K	0.06%	38
2013 Q2	$368K	Buy	+7,785	New	+$396K	0.06%	43

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MDE Group's AZN Position: Q1 2015 in Review

MDE Group held its AstraZeneca (AZN) position steady in Q1 2015 at 3,463 shares worth $237K. The position accounts for 0.06% of the portfolio, ranked #52.

MDE Group first reported a position in AZN in Q2 2013 and has held it in 8 quarters since. The position peaked at $477K in Q1 2014. 386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

MDE Group held 3,463 shares of AstraZeneca worth $237K as of Q1 2015.
MDE Group left its AstraZeneca share count unchanged in Q1 2015.
AstraZeneca made up 0.06% of MDE Group's portfolio in Q1 2015, its #52 holding.
MDE Group first reported a position in AstraZeneca in Q2 2013 and has held it in 8 quarters since.
MDE Group's AstraZeneca position peaked at $477K in Q1 2014.
386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on MDE Group's 13F filing for Q1 2015, filed 22 Apr 2015.